Nobel Laureate David Baker Pushes AI-Driven Protein Design Beyond Nature's Limits
David Baker, who won the Nobel Prize for his pioneering work on protein design, is now at the forefront of using artificial intelligence to create molecules that do not exist in the natural world. In recent interviews, Baker discussed how AI tools are dramatically accelerating the design of proteins with entirely new structures and functions—potentially enabling new therapeutics, materials, and biochemical processes.
Baker's lab at the University of Washington has developed and refined computational methods that go beyond simply mimicking natural proteins. Instead, AI models can now propose novel amino acid sequences and folds that nature never evolved, opening a vast new chemical space for biotechnology. This capability raises profound questions about biosafety, intellectual property, and regulatory oversight, as these designed molecules could interact with biological systems in unpredictable ways.
The convergence of AI and synthetic biology represents a shift from modifying existing life to constructing entirely new biological parts. Baker emphasizes both the tremendous potential—such as tailored treatments for diseases—and the need for careful consideration of risks as the field moves forward.